Cited by 2,834Antibiotic Resistance in BacteriaAntibiotic Use and ResistanceAntimicrobial Resistance in Staphylococcus

The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.

The Crisis in Antibiotic Resistance

Neu, Harold C.·1992·Science

Open this paper in CoChat — free account

Abstract

The synthesis of large numbers of antibiotics over the past three decades has caused complacency about the threat of bacterial resistance. Bacteria have become resistant to antimicrobial agents as a result of chromosomal changes or the exchange of the exchange of genetic material via plasmids and transposons. Streptococcus pneumoniae, Streptococcus pyogenes, and staphylococci, organisms that cause respiratory and cutaneous infections, and members of the Enterobacteriaceae and Pseudomonas families, organisms that cause diarrhea, urinary infection, and sepsis, are now resistant to virtually all of the older antibiotics. The extensive use of antibiotics in the community and hospitals has fueled this crisis. Mechanisms such as antibiotic control programs, better hygiene, and synthesis of agents with improved antimicrobial activity need to be adopted in order to limit bacterial resistance.

Integrity signals

Registry

Crossref · 10.1126/science.257.5073.1064

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,887
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,411
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 887
Pneumococcal resistance to antibiotics
Klugman, K. P. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.2.171 · Cited by 804
Extended-spectrum beta-lactamases
Philippon, A., Labia, R., & Jacoby, G. A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1131 · Cited by 776
More extended-spectrum beta-lactamases
Jacoby, G. A., & Medeiros, A. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1697 · Cited by 704
Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA
Bugg, T. D. H., Wright, G. D., Dutka‐Malen, S., Arthur, M., Courvalin, P. M., & Walsh, C. T. (1991) · Biochemistry · doi:10.1021/bi00107a007 · Cited by 642
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Leclercq, R., & Courvalin, P. M. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1267 · Cited by 629
Active efflux of tetracycline encoded by four genetically different tetracycline resistance determinants in Escherichia coli.
McMurry, L. M., Petrucci, R., & Levy, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3974 · Cited by 606
Antimicrobial resistance of Staphylococcus aureus: genetic basis
Lyon, B. R., & Skurray, R. A. (1987) · Microbiological Reviews · doi:10.1128/mr.51.1.88-134.1987 · Cited by 593

Show all 109 references

Research works printed but not linked: 30

AMERICAN JOURNAL OF MEDICINE 91 3B (1991).
APPELBAUM, P. C., EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 6: 367 (1987).
BANERJEE, S.N., SECULAR TRENDS IN NOSOCOMIAL PRIMARY BLOOD-STREAM INFECTIONS IN THE UNITED-STATES, 1980-1989, AMERICAN JOURNAL OF MEDICINE 91: S86 (1991).
BOYCE, J. M., JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 249: 2803 (1983). · DOI
Bryan, L. E., Antimicrobial Drug Resistance 241 (1984).
BUOHO, A. Y., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 22 B: 41 (1988).
BUSH, K, ANTIMICROB AGENTS CH 33: 339 (1989).
COOKSON, B. D., JOURNAL OF APPLIED BACTERIOLOGY 69: 55S (1990).
DEGUCHI, K, JAPANESE JOURNAL OF ANTIBIOTICS 42: 2133 (1990).
Fisher, M., New Antibacterial Strategies 177 (1990).
Higgins, C. F., New Antibacterial Strategies 193 (1990).
KHARDORI, N, REVIEWS OF INFECTIOUS DISEASES 12: 996 (1990).
LUJAN, R, REVISTA ESPANOLA DE QUIMIOTERAPIA 3: 323 (1990).
McMurry, L., Proceedings of the National Academy of Sciences of the United States of America 77: 3974 (1980).
MILATOVIC, D, EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 6: 234 (1987).
Mitsuhashi, S., The Aminoglycosides 97 (1982).
MOELLERING, R, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 28: 1 (1991).
MUDDER, R.R., ARCH INTERN MED 147: 1672 (1987). · DOI
NEU, H. C., AMERICAN JOURNAL OF MEDICINE 76: 11 (1984).
NEU, H.C., AMERICAN JOURNAL OF MEDICINE 7 5A: 2 (1985).
Neu, H. C., Human Pharmacology 613 (1991).
Normark, S., New Antibacterial Strategies 161 (1990).
PHILLIPS, I, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 27: 40 (1991).
SCHABERG, D. R., AMERICAN JOURNAL OF MEDICINE 91 3B: 725 (1991).
SKURRAY, R. A., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 21 C: 19 (1988).
SLOCOMBE, B,JOURNAL OF HOSPITAL INFECTION 19: 19 (1991).
SMITH, A, INFECTIOUS DISEASE CLINICS OF NORTH AMERICA 5: 177 (1992).
TALLY, F. P., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 22 A: 63 (1989).
TENOVER, F. C., AMERICAN JOURNAL OF MEDICINE 91: S76 (1991).
UTTLEY, AHC, VANCOMYCIN-RESISTANT ENTEROCOCCI, LANCET 1: 57 (1988).

Sorted by citations

Ventilator-associated Pneumonia
Chastre, J. E., & Fagon, J.-Y. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.7.2105078 · Cited by 2,884
“The indiscriminate administration of antimicrobial agents to patients in the ICU may have immediate but also long-term consequences, contributing to the emergence of multiresistant pathogens and increasing the risk of severe superinfections (336, 339).”
Silver Colloid Nanoparticles: Synthesis, Characterization, and Their Antibacterial Activity
Panáček, A., Kvı́tek, L., Prucek, R., Kolář, M., Večeřová, R., Pizúrová, N., Sharma, V. K., Nevěčná, T., & Zbořil, R. (2006) · The Journal of Physical Chemistry B · doi:10.1021/jp063826h · Cited by 2,339
The challenge of emerging and re-emerging infectious diseases
Morens, D. M., Folkers, G. K., & Fauci, A. S. (2004) · Nature · doi:10.1038/nature02759 · Cited by 2,153
Inactivation of Antibiotics and the Dissemination of Resistance Genes
DAVIES, J. E. (1994) · Science · doi:10.1126/science.8153624 · Cited by 1,729
Mechanisms of Antimicrobial Resistance in Bacteria
Tenover, F. C. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.011 · Cited by 1,747
Molecular mechanisms that confer antibacterial drug resistance
Walsh, C. T. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,579
“This multiplicity also indicates that protein synthesis will provide a multifaceted target for new antibiotics and this is the mechanism for the action of oxazolidinone”
Background
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,542
Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults: A Randomized Trial
Chastre, J., Wolff, M., Fagon, J.-Y., Chevret, S., Thomas, F., Wermert, D., Clementi, E., Gonzalez, J., Jusserand, D., Asfar, P., et al. (2003) · JAMA · doi:10.1001/jama.290.19.2588 · Cited by 1,376
“Although appropriate antibiotics may improve the survival rate of patients with VAP, their indiscriminate use in treating ICU patients without infection should probably be discouraged.(5,10,32) It is widely accepted that nonfermenting gram-negative bacilli, especially P aeruginosa, are difficult to eradicate from the…”
Background
The threat of antimicrobial resistance in developing countries: causes and control strategies
Ayukekbong, J. A., Ntemgwa, M., & Atabe, A. N. (2017) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-017-0208-x · Cited by 1,315
“This practice contributes to the development of resistance [24] as the drug applies selective pressure, not only upon the etiological agent of the disease episode but also upon a large fraction of the patient’s microbiota [25].”
Background
Environmental Contamination Due to Methicillin-Resistant Staphylococcus aureus: Possible Infection Control Implications
Boyce, J. M., Potter-Bynoe, G., Chenevert, C., & King, T. (1997) · Infection Control and Hospital Epidemiology · doi:10.1086/502213 · Cited by 1,758
“minor variations on such mechanisms have been described.(2) For example, shortly after penicillin began to be used for clinical therapy, penicillinase was discovered.”
Background
Factors in the Emergence of Infectious Diseases
Morse, S. S. (1995) · Emerging infectious diseases · doi:10.3201/eid0101.950102 · Cited by 1,272
“Selection for antibiotic-resistant bacteria (5,36) and drug-resistant parasites has become frequent, driven by the wide and sometimes inappropriate use of antimicrobial drugs in a variety of applications (27,45,46).”
Bacteriocins: Evolution, Ecology, and Application
Riley, M. A., & Wertz, J. E. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.161024 · Cited by 1,236
“The rapid rise and spread of multi-resistant bacterial pathogens have forced the consideration of alternative methods of combating infection (59, 78).”
Background
Structural Violence and Clinical Medicine
Farmer, P. E., Nizeye, B., Stulac, S. N., & Keshavjee, S. A. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030449 · Cited by 1,160
Acquired Antibiotic Resistance Genes: An Overview
van Hoek, A. H. A. M., Mevius, D. J., Guerra, B., Mullany, P. P., Roberts, A. P., & Aarts, H. J. M. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00203 · Cited by 1,194
“Nowadays numerous different classes of antimicrobial agents are known and they are classified based on their mechanisms of action (Neu, 1992).”
Background
Modular Peptide Synthetases Involved in Nonribosomal Peptide Synthesis
Marahiel, M. A., Stachelhaus, T., & Mootz, H. D. (1997) · Chemical Reviews · doi:10.1021/cr960029e · Cited by 1,128
Combatting antibiotic-resistant bacteria using nanomaterials
Gupta, A., Mumtaz, S., Li, C., Hussaın, I., & Rotello, V. M. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00748e · Cited by 1,135
Perspectives on the use of organic acids and short chain fatty acids as antimicrobials
Ricke, S. C. (2003) · Poultry Science · doi:10.1093/ps/82.4.632 · Cited by 1,032
“Antibiotic supplementation in farm animal diets to improve animal growth performance and efficiency of feed conversion, historically, has been theorized as a means of establishing food animals as reservoirs for antibioticresistant pathogens isolated from humans (Smith, 1968; Levy et al., 1976; Armstrong, 1984; Neu, 19…”
Background
Antibiotic Pollution in the Environment: From Microbial Ecology to Public Policy
Kraemer, S. A., Ramachandran, A., & Perron, G. G. (2019) · Microorganisms · doi:10.3390/microorganisms7060180 · Cited by 1,063
“This prognostic directed world leaders to call for an immediate reduction in antibiotic use [8,13,14].”
Background
The Structural Basis for the Action of the Antibiotics Tetracycline, Pactamycin, and Hygromycin B on the 30S Ribosomal Subunit
Brodersen, D. E., Clemons, W. M., Carter, A. P., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000) · Cell · doi:10.1016/s0092-8674(00)00216-6 · Cited by 950
Strategies for combating bacterial biofilm infections
Wu, H., Moser, C., Wang, H.-Z., Høiby, N., & Song, Z.-J. (2015) · International Journal of Oral Science · doi:10.1038/ijos.2014.65 · Cited by 925
Models of cooperation based on the Prisoner's Dilemma and the Snowdrift game
Doebeli, M., & Hauert, C. (2005) · Ecology Letters · doi:10.1111/j.1461-0248.2005.00773.x · Cited by 868
“Antibiotic resistance in bacteria: Resistance to b-lactam antibiotics is often because ofbacteria secreting an enzyme, b-lactamase, that is responsible for inhibiting bacterial cell wall synthesis ( Neu 1992 ).”
Background
The Challenge of Antibiotic Resistance
Levy, S. B. (1998) · Scientific American · doi:10.1038/scientificamerican0398-46 · Cited by 867
Global Surveillance for Antituberculosis-Drug Resistance, 1994–1997
Pablos-Méndez, A., Raviglione, M. C., Laszlo, A., BINKIN, N. J., Rieder, H. L., Bustreo, F., Cohn, D. L., Weezenbeek, C. S. B. L.-V., Kim, S., Chaulet, P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382301 · Cited by 814
Molecular Properties of Bacterial Multidrug Transporters
Putman, M., van Veen, H. W., & Konings, W. N. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.672-693.2000 · Cited by 811
“However, the subsequent appearance and spread of antibiotic resistance in pathogenic organisms have made many currently available antibiotics ineffective (160, 169).”
Background
Trends in Antimicrobial Drug Prescribing Among Office-Based Physicians in the United States
McCaig, L. F. (1995) · JAMA · doi:10.1001/jama.1995.03520270048030 · Cited by 790
Developing a new resource for drug discovery: marine actinomycete bacteria
Fenical, W., & Jensen, P. R. (2006) · Nature Chemical Biology · doi:10.1038/nchembio841 · Cited by 787
“Given the urgent need for new antibiotics to stem the tide of drug-resistant pathogen”
Background
The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance
Austin, D. J., Kristinsson, K. G., & Anderson, R. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.1152 · Cited by 784
Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals
Shlaes, D. M., Gerding, D. N., John, J. F., Craig, W. A., Bornstein, D. L., Duncan, R. A., Eckman, M. R., Farrer, W. E., Greene, W. H., Lorian, V., et al. (1997) · Clinical Infectious Diseases · doi:10.1086/513766 · Cited by 781
Functional Gold Nanoparticles as Potent Antimicrobial Agents against Multi-Drug-Resistant Bacteria
Li, X., Robinson, S. M., Gupta, A., Saha, K., Jiang, Z., Moyano, D. F., Sahar, A. Z., Riley, M. A., & Rotello, V. M. (2014) · ACS Nano · doi:10.1021/nn5042625 · Cited by 768
“T he emergence of multi-drug-resistant (MDR) bacteria has become a severe threat to public health.(1) According to”
Background
Role of Peptide Hydrophobicity in the Mechanism of Action of α-Helical Antimicrobial Peptides
Chen, Y., Guarnieri, M. T., Vasil, A. I., Vasil, M. L., Mant, C. T., & Hodges, R. S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00925-06 · Cited by 759
“Antibiotic resistance, due to the extensive clinical use of classical antibiotics (22, 32), has become a great concern in recent years, prompting an urgent need for a new class of antibiotics.”
Background
Fate of antibiotics during municipal water recycling treatment processes
Le-Minh, N., Khan, S. J., Drewes, J. E., & Stuetz, R. M. (2010) · Water Research · doi:10.1016/j.watres.2010.06.020 · Cited by 778
“many species to inactivate the pharmacological effects of the beta-lactam antibiotics (Neu, 1992).”
Background
Resistance to Antibiotics Mediated by Target Alterations
Spratt, B. G. (1994) · Science · doi:10.1126/science.8153626 · Cited by 673
Creating and Maintaining the Gastrointestinal Ecosystem: What We Know and Need To Know from Gnotobiology
Falk, P. G., Hooper, L. V., Midtvedt, T., & Gordon, J. I. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1157-1170.1998 · Cited by 658
Effect of Abolishment of the Use of Antimicrobial Agents for Growth Promotion on Occurrence of Antimicrobial Resistance in Fecal Enterococci from Food Animals in Denmark
Aarestrup, F. M., Seyfarth, A. M., Emborg, H., Pedersen, K., Hendriksen, R. S., & Bager, F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2054-2059.2001 · Cited by 653
“Multiply resistant pathogenic bacteria have emerged worldwide during the last couple of decades, and multiple antimicrobial resistance is now one of the serious concerns of the new millennium (15, 23, 28).”
Background
Mechanisms of antimicrobial resistance in bacteria
Tenover, F. C. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.219 · Cited by 672
Antibiotic resistance of faecal Escherichia coli in poultry, poultry farmers and poultry slaughterers
van den Bogaard, A. E. J. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.6.763 · Cited by 622
Natural Products as Platforms To Overcome Antibiotic Resistance
Rossiter, S. E., Fletcher, M. H., & Wuest, W. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00283 · Cited by 622
Antibiotic Use in Agriculture and Its Impact on the Terrestrial Environment
Kumar, K., Gupta, S. C., Chander, Y., & Singh, A. K. (2005) · Advances in agronomy · doi:10.1016/s0065-2113(05)87001-4 · Cited by 637
Rational Design of α-Helical Antimicrobial Peptides with Enhanced Activities and Specificity/Therapeutic Index
Chen, Y., Mant, C. T., Farmer, S. W., Hancock, R. E. W., Vasil, M. L., & Hodges, R. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413406200 · Cited by 601
Pharmacological significance of triazole scaffold
Kharb, R., Sharma, P. C., & Yar, M. S. (2010) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756360903524304 · Cited by 612
Protein Phylogenies and Signature Sequences: A Reappraisal of Evolutionary Relationships among Archaebacteria, Eubacteria, and Eukaryotes
Gupta, R. S. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1435-1491.1998 · Cited by 598
Alpha-helical cationic antimicrobial peptides: relationships of structure and function
Yi, H., Huang, J., & Chen, Y. (2010) · Protein & Cell · doi:10.1007/s13238-010-0004-3 · Cited by 575
“(Neu, 1992); however, due to mutations and adaptation in bacteria, the traditional antibiotics eventually become inefficient (Bryan, 1988).”
Background
Developing new antimicrobial therapies: Are synergistic combinations of plant extracts/compounds with conventional antibiotics the solution?
Cock, I. E., Cheesman, M. J., Ilanko, A., & Blonk, B. (2017) · Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review · doi:10.4103/phrev.phrev_21_17 · Cited by 583
“Modified β-lactams and β-lactamase inhibitors provided effective treatment and management of the entire Enterobacteriaceae family.[10] Another novel class of antibiotics would not be introduced again until 1989.”
Background
Low Dosage and Long Treatment Duration of β-Lactam
Guillemot, D., Carbon, C., Balkau, B., Geslin, P., Lecoeur, H., Vauzelle-Kervroedan, F., Bouvenot, G., & Eschwège, É. (1998) · JAMA · doi:10.1001/jama.279.5.365 · Cited by 545
Self-Healing Conductive Injectable Hydrogels with Antibacterial Activity as Cell Delivery Carrier for Cardiac Cell Therapy
Dong, R., Zhao, X., Guo, B., & Ma, P. X. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b04911 · Cited by 543
Bacterial resistance to antibiotics: Active efflux and reduced uptake
Kumar, A., & Schweizer, H. P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.004 · Cited by 569
“However, widespread antibiotic use has promoted the emergence of antibiotic-resistant pathogens, including multidrug resistant strains [1–3].”
Background
Excessive antibiotic use for acute respiratory infections in the United States
Gonzales, R., Malone, D. C., Maselli, J. H., & Sande, M. A. (2001) · Clinical Infectious Diseases · doi:10.1086/322627 · Cited by 531
Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians
Gonzales, R. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550110039033 · Cited by 717
Use of antimicrobial agents in veterinary medicine and food animal production
Schwarz, Š., Kehrenberg, C., & Walsh, T. R. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00297-7 · Cited by 525
“are considered the only ones which can be traced to animal sources with a high degree of certainty [14–16].”
Background
The Perpetual Challenge of Infectious Diseases
Fauci, A. S., & Morens, D. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1108296 · Cited by 550
Synthesis of silver nanoparticles using Dioscorea bulbifera tuber extract and evaluation of its synergistic potential in combination with antimicrobial agents
Chopade, B. A., Ghosh, S., Patil, Ahire, Kitture, R., Jabgunde, A. M., Kale, S. N., Pardesi, K. R., Cameotra, Bellare, J. R., et al. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s24793 · Cited by 528
“16–20 Of all the inorganic antimicrobial agents, silver elements and nanoparticle compounds have been the most extensively tested.”
Phenolic compounds and antimicrobial activity of olive (Olea europaea L. Cv. Cobrançosa) leaves
Pereira, A. P., Ferreira, I. C., Marcelino, F., Valentão, P., Andrade, P. B., Seabra, R., Estevinho, L., Bento, A., & Pereira, J. A. (2007) · Molecules · doi:10.3390/12051153 · Cited by 519
“Olive leaves may be useful in cases where prolonged use of antibiotics encourage development of opportunistic infections [26], being especially effective against Klebsiella and Pseudomonas, two bacterial genera which pose a major resistance problem [27].”
Background
Trends in Antimicrobial Prescribing Rates for Children and Adolescents
McCaig, L. F. (2002) · JAMA · doi:10.1001/jama.287.23.3096 · Cited by 518
Interactions among Strategies Associated with Bacterial Infection: Pathogenicity, Epidemicity, and Antibiotic Resistance
Martínez, J. L., & Baquero, F. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.647-679.2002 · Cited by 512
Synergistic antibacterial effects of β-lactam antibiotic combined with silver nanoparticles
Li, P., Li, J., Wu, C., Wu, Q., & Li, J. (2005) · Nanotechnology · doi:10.1088/0957-4484/16/9/082 · Cited by 508
Reductase Activity Encoded by the HM1 Disease Resistance Gene in Maize
Johal, G. S., & Briggs, S. P. (1992) · Science · doi:10.1126/science.1359642 · Cited by 505
Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections
Hu, X., Huang, Y., Wang, Y., Wang, X., & Hamblin, M. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01299 · Cited by 508
“The increase in genetic diversity within biofilms, facilitates adaption to antibiotics, and various drugresistant variants have been reported to arise due to chromosomal mutation, induction of expression of latent genes, and exchange of genetic material between cells (Neu, 1992).”
Background
The Relationship Between Perceived Parental Expectations and Pediatrician Antimicrobial Prescribing Behavior
Mangione-Smith, R., McGlynn, E., Elliott, M., Krogstad, P., & Brook, R. (1999) · Pediatrics · doi:10.1542/peds.103.4.711 · Cited by 502
Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study
Arason, V. A., Kristinsson, K. G., Sigurdsson, J. A., Stefansdottir, G., Mölstad, S., & Gudmundsson, S. (1996) · BMJ · doi:10.1136/bmj.313.7054.387 · Cited by 493
The occurrence, distribution and degradation of antibiotics by ionizing radiation: An overview
Wang, J., Zhuan, R., & Chu, L. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.07.415 · Cited by 470
Structure of the Cell Wall Anchor of Surface Proteins in Staphylococcus aureus
Schneewind, O., Fowler, A. V., & Faull, K. F. (1995) · Science · doi:10.1126/science.7701329 · Cited by 447
Antibiotic mediated synthesis of gold nanoparticles with potent antimicrobial activity and their application in antimicrobial coatings
Rai, A., Prabhune, A. A., & Perry, C. C. (2010) · Journal of Materials Chemistry · doi:10.1039/c0jm00817f · Cited by 449
The Economic Impact of Staphylococcus aureus Infection in New York City Hospitals
Rubin, R. J., Harrington, C. A., Poon, A., Dietrich, K. A., Greene, J. A., & Moiduddin, A. (1999) · Emerging infectious diseases · doi:10.3201/eid0501.990102 · Cited by 444
“aureus infections worldwide do not respond to first-line antibiotics such as penicillin or ampicillin (5).”
Background
Combating Multidrug‐Resistant Bacteria: Current Strategies for the Discovery of Novel Antibacterials
O’Connell, K. M. G., Hodgkinson, J. T., Sore, H. F., Welch, M., Salmond, G. P. C., & Spring, D. R. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201209979 · Cited by 436
Genetically Engineered Phages: a Review of Advances over the Last Decade
Pires, D. P., Cleto, S., Sillankorva, S., Azeredo, J., & Lu, T. K. (2016) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00069-15 · Cited by 441
Essential Oils, A New Horizon in Combating Bacterial Antibiotic Resistance
Yap, P. S. X., Yiap, B. C., Ping, H. C., & Lim, S. H. E. (2014) · The Open Microbiology Journal · doi:10.2174/1874285801408010006 · Cited by 426
Market potential for probiotics
Stanton, C., Gardiner, G. E., Meehan, H., Collins, K. J., Fitzgerald, G. F., Lynch, P. B., & Ross, R. P. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.476s · Cited by 416
EMERGING AND RE-EMERGING INFECTIOUS DISEASES: The Third Epidemiologic Transition
Barrett, R., Kuzawa, C. W., McDade, T. W., & Armelagos, G. J. (1998) · Annual Review of Anthropology · doi:10.1146/annurev.anthro.27.1.247 · Cited by 438
Antibacterial Agents That Inhibit Lipid A Biosynthesis
Onishi, H. R., PELAK, B. A., Gerckens, L. S., Silver, L. L., Kahan, F. M., Chen, M., Patchett, A. A., Galloway, S. M., Hyland, S. A., Anderson, M. S., et al. (1996) · Science · doi:10.1126/science.274.5289.980 · Cited by 413
Ventilator-Associated Pneumonia
(2012) · Springer eBooks · doi:10.1007/springerreference_225126 · Cited by 406
Proteolytic cleavage and cell wall anchoring at the LPXTG motif of surface proteins in Gram‐positive bacteria
Navarre, W. W., & Schneewind, O. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb01271.x · Cited by 393
Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story
Walsh, C. T., Fisher, S. L., Park, I.-S., Prahalad, M. K., & Wu, Z. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90079-4 · Cited by 385
Antimicrobial resistance in gram-positive bacteria
Rice, L. B. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.220 · Cited by 393
Role of Quantitative Cultures of Endotracheal Aspirates in the Diagnosis of Nosocomial Pneumonia
Jourdain, B., Novara, A., Joly‐Guillou, M., Dombret, M.-C., Calvat, S., Trouillet, J., Gibert, C., & Chastre, J. E. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.1.7599831 · Cited by 379
Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones
Ferrero, L., Cameron, B., Manse, B., Lagneaux, D., Crouzet, J., Famechon, A., & Blanche, F. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00458.x · Cited by 378
Acquired antibiotic resistance in lactic acid bacteria from food
Teuber, M., Meile, L., & Schwarz, F. (1999) · Antonie van Leeuwenhoek · doi:10.1023/a:1002035622988 · Cited by 377
“For certain pathogenic and potentially pathogenic bacteria like staphylococci and enterococci, the evolution of highly resistant clones has inaugurated a crisis in antibiotic resistance (Neu 1992).”
Background
Therapeutic Potential of Boron-Containing Compounds
Baker, S. J., Ding, C. Z., Akama, T., Zhang, Y.-K., Hernandez, V. S., & Xia, Y. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.71 · Cited by 377
Antimicrobial peptides under clinical investigation
Koo, H. B., & Seo, J. (2019) · Peptide Science · doi:10.1002/pep2.24122 · Cited by 387
An iron-regulated sortase anchors a class of surface protein during Staphylococcus aureus pathogenesis
Mazmanian, S. K., Ton-That, H., Su, K., & Schneewind, O. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032523999 · Cited by 372
Patterns of Antimicrobial Resistance Observed in Escherichia coli Isolates Obtained from Domestic- and Wild-Animal Fecal Samples, Human Septage, and Surface Water
Sayah, R. S., Kaneene, J. B., Johnson, Y. J., & Miller, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.3.1394-1404.2005 · Cited by 369
“Antimicrobial agent resistance has been recognized as an emerging worldwide problem in both human and veterinary medicine, and antimicrobial agent use is considered the most important factor for the emergence, selection, and dissemination of antimicrobial agent-resistant bacteria (29, 51).”
Background
Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam
Go, E., Urban, C. M., Burns, J. M., Mariano, N., Mosinka-Snipas, K., Rahal, J. J., Kreiswirth, B. N., & Eisner, W. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90694-7 · Cited by 369
Nano-structured antimicrobial surfaces: From nature to synthetic analogues
Elbourne, A. J., Crawford, R. J., & Ivanova, E. P. (2017) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2017.07.021 · Cited by 374
“In recent decades, biofilm formation has become a world-wide research challenge [1, 4, 5, 23, 24] because the instances of both antimicrobial resistance and postoperative infection are substantially and dramatically increasing.”
Background
A clinical score to reduce unnecessary antibiotic use in patients with sore throat.
McIsaac, W. J., White, D., Tannenbaum, D., & Low, D. E. (1998) · Europe PMC (PubMed Central) · Cited by 361
Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance
Hinrichs, W., Kisker, C., Düvel, M., Müller, A., Tovar, K., Hillen, W., & Saenger, W. (1994) · Science · doi:10.1126/science.8153629 · Cited by 408
Crystal structure of Escherichia coli TEM1 β‐lactamase at 1.8 Å resolution
Jelsch, C., Mourey, L., Masson, J., & Samama, J. (1993) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340160406 · Cited by 361
Vancomycin Assembly: Nature's Way
Hubbard, B. K., & Walsh, C. T. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390202 · Cited by 356
The role of vaccines in preventing bacterial antimicrobial resistance
Jansen, K. U., Knirsch, C. A., & Anderson, A. S. (2018) · Nature Medicine · doi:10.1038/nm.4465 · Cited by 355
Decreasing Antibiotic Use in Ambulatory Practice
Gonzales, R. (1999) · JAMA · doi:10.1001/jama.281.16.1512 · Cited by 352
Bacterial pathogens in wild birds: a review of the frequency and effects of infection
Benskin, C., Wilson, K. L., Jones, K., & Hartley, I. R. (2009) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/j.1469-185x.2008.00076.x · Cited by 351
“The use of antibiotics is deemed to be the most important factor promoting the emergence, selection and dissemination of antibiotic-resistant microorganisms in both veterinary and human medicine (Neu, 1992; Witte, 1998).”
Background
Antimicrobial Cluster Bombs: Silver Nanoclusters Packed with Daptomycin
Zheng, K., Setyawati, M. I., Lim, T.-P., Leong, D. T., & Xie, J. (2016) · ACS Nano · doi:10.1021/acsnano.6b03862 · Cited by 350
Emergence and Rapid Spread of Carbapenem Resistance during a Large and Sustained Hospital Outbreak of MultiresistantAcinetobacter baumannii
Corbella, X., Montero, A., Pujol, M., Domínguez, M. Á., Ayats, J., Argerich, M. J., Garrigosa, F., Ariza, J., & Gudiol, F. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.11.4086-4095.2000 · Cited by 347
“(%) of patients with CR-Ab fecal carriage prior to isolation 16 (52) 3 (5) ,0.”
Background
Infection of orthopedic implants and the use of antibiotic-loaded bone cements: A review
van de Belt, H., Neut, D., Schenk, W., van Horn, J. R., van der Mei, H. C., & Busscher, H. J. (2001) · Acta Orthopaedica Scandinavica · doi:10.1080/000164701317268978 · Cited by 341
Distribution and Physiology of ABC-Type Transporters Contributing to Multidrug Resistance in Bacteria
Lubelski, J., Konings, W. N., & Driessen, A. J. M. (2007) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00001-07 · Cited by 339
“However, quickly after the introduction of antibiotics, bacteria developed various ways to reverse their actions (70, 71, 94, 148).”
Background
Antibiotic selective pressure and development of bacterial resistance
Kolář, M., Urbánek, K., & Látal, T. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00317-x · Cited by 336
Molecular understanding of aminoglycoside action and resistance
Jana, S., & Deb, J. K. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-005-0279-0 · Cited by 335
“Nevertheless, resistance to aminoglycosides requires long periods of exposure or very large inoculums of organisms and occurs less frequently than with other agents, such as third-generation cephalosporins, which are also effective against Gram-negative organisms (Neu 1992).”
Background
Structure-based drug design: progress, results and challenges
Verlinde, C. L. M. J., & Hol, W. G. J. (1994) · Structure · doi:10.1016/s0969-2126(00)00060-5 · Cited by 331
“The processes used by resistant organisms and cancer cells to avoid the harmful effects of a drug vary widely [74].”
The antibacterial activity of extracts of nine plant species with good activity against Escherichia coli against five other bacteria and cytotoxicity of extracts
Elisha, I. L., Botha, F. S., McGaw, L. J., & Eloff, J. N. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-017-1645-z · Cited by 329
“involved in the pathogenesis of respiratory and skin infections, along with Pseudomonads and members of the Enterobacteriaceae causing gastrointestinal, urogenital diseases and wound contamination are resistant to virtually all of the older antibiotics [5].”
Background
Antimicrobial Resistance in Gram-Positive Bacteria
Rice, L. B. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.012 · Cited by 330
Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis.
Cheung, A. L., Eberhardt, K. J., Chung, E., Yeaman, M. R., Sullam, P. M., Ramos, M., & Bayer, A. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117530 · Cited by 327
“Volume 94, November 1994, 1815-1822 has made many currently available antimicrobial agents (including fluoroquinolones) ineffective, thereby posing an important public health problem (2, 3).”
Background
Antibiotic Usage in Animals
van den Bogaard, A. E. J. M., & Stobberingh, E. E. (1999) · Drugs · doi:10.2165/00003495-199958040-00002 · Cited by 319
“been recently reported that organisms resistant to all clinically available antibiotics have emerged.[1,2]”
Background

Authors: Neu, H. C.
Affiliations: Columbia University (US)
Corresponding author: Neu, Harold C.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1992-08-21
Volume: 257
Issue: 5073
Pages: 1064-1073
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.257.5073.1064
OpenAlex: W1980595924
Cited by: 2,834
References: 109
Citations by year: 2026: 23 · 2025: 48 · 2024: 57 · 2023: 71 · 2022: 91 · 2021: 93 · 2020: 123 · 2019: 100 · 2018: 122 · 2017: 123 · 2016: 105 · 2015: 87 · 2014: 95 · 2013: 109 · 2012: 99
FWCI: 46.70
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords: antibiotic resistance, bacterial resistance, plasmids, transposable elements, horizontal gene transfer, Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus, Enterobacteriaceae, Pseudomonas, antibiotic overuse, hygiene, novel antimicrobial agents
MeSH terms: Anti-Bacterial Agents, Bacterial Infections, Cross Infection, Drug Resistance, Microbial, Enterobacteriaceae, Haemophilus influenzae, Humans, Staphylococcus, Streptococcus pneumoniae, Streptococcus pyogenes, Enterococcus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Crisis in Antibiotic Resistance

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks